NL-OMON53120招募中不适用
Costimulatory and co-inhibitory molecules on tumor-infiltrating lymphocytes from hepatocellular carcinoma and cholangiocarcinoma - Costimulatory and co-inhibitory molecules in HCC and CCA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 272
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Adult hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCA) patients that
- •will undergo surgery for this disease
排除标准
- •Patients who refuse blood donation/participation in the study
- •Patients with a severe immunocompromised condition, or patients taking
- •immunosuppressive medication
研究者
相似试验
招募中
不适用
Costimulatory and -inhibitory molecules on tumor-infiltrating lymphocytes from colorectal carcinoma and its metastasesbowel cancercolorectal carcinoma10017991NL-OMON43140Stichting Leveronderzoek677
招募中
不适用
Co-stimulatory and -inhibitory molecules on tumor-infiltrating lymphocytes from cholangiocarcinomabile duct cancer10019815cholangiocarcinomaNL-OMON43309Stichting Leveronderzoek102
已完成
不适用
Investigation of correlation between antitumor effect of combined lapatinib/capecitabine therapy and p95HER2, PTEN and PIK3CA in patients with HER2 positive breast cancerBreast cancerJPRN-UMIN000007153Kyushu Breast Cancer Study Group200
已完成
1 期
Chemotherapy in Treating Patients With Advanced Solid TumorsUnspecified Adult Solid Tumor, Protocol SpecificNCT00003721The University of Texas Health Science Center at San Antonio33
进行中（未招募）
1 期
A study of the use of apalutamide (ARN509) to reduce tumour volumes in men on active surveillance for prostate cancerEUCTR2017-001700-29-GBCambridge University Hospitals NHS Foundation Trust & The University of Cambridge10